Skip to main content

The AACR Annual Meeting brings together the best minds in cancer research from institutions across the world.  It provides the research community a platform to share the latest advancements in cancer science; from cancer biology, to translational, and clinical studies.

Bio-Techne is uniquely positioned to empower the cancer research community to discover, validate, and verify meaningful conclusions through the use of its innovative product and service solutions. This allows scientists to make quick decisions that drive discovery for diagnostic and therapeutic research.


Get to know Bio-Techne

Bio-Techne Intro Video

Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services.

Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results. Whether you are at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our innovative products and services provide the solutions you need to achieve success.

What else to look for at AACR?

Bio-Techne will be bringing innovative research to the community through the following posters:

​​​​​Spatial analysis of tumor-infiltrated immune cells with highly
specific RNAscope™ RNA-protein Co-Detection assays

  • Presenter: Anushka Dikshit
  • Session Title: Tumor Immune Profiling and Spatial Analysis
  • Session Category: Tumor Biology
  • Session Date and Time: Monday Apr 11, 2022, 1:30 PM - 5:00 PM
  • Poster Board Number: 20

Spatial multiplex profiling of immune cell markers in FFPE tumor tissues using the RNAscope™ HiPlex v2 in situ hybridization assay

  • Presenter: Sayantani Basak
  • Session Title: Models and Technical Approaches to Analyze and Examine the Tumor Microenvironment
  • Session Category: Tumor Biology
  • Session Date and Time: Wednesday Apr 13, 2022, 9:00 AM - 12:30 PM
  • Poster Board Number: 10

Exosome-based Plasma RNA Biomarkers for High-Risk Prostate Cancer

Bio-Techne partnering with University of Miami

  • Presenter: Sandra M. Gaston PhD
  • Session Title: Exosome-based Plasma RNA Biomarkers for High-Risk Prostate Cancer
  • Co-authors include members of:
    • Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA
      Urology, University of Miami Miller School of Medicine, Miami, Florida, USA
    • Exosome Diagnostics, Inc., a Bio-Techne brand, Waltham, Massachusetts, USA
    • Exosome Diagnostics GmbH, a Bio-Techne brand, Martinsried, Germany

Preoperative D-Dimer and Tissue Factor activity predict postoperative venous thromboembolism in glioma patients

  • Presenter: Dusten Unruh
  • Session Date and Time: Sunday Apr 10, 2022, 1:30 PM - 4:00 PM
  • Exhibit Halls D-H, poster section 31,
  • Poster Board Number: 20
Bio-Techne booth design at AACR 2022


3D Tumor cell in targeted immunotherapy research

Exploiting Tumor Hypoxia for Targeted Immunotherapy

Dr. Greg M. Delgoffe (University of Pittsburgh) and Dr. James Arnold (King's College London) discuss how hypoxia-driven metabolic changes in T cells can lead to T cell exhaustion and share strategies to improve cellular immunotherapy by exploiting the hypoxia, in this webinar.

molecule in gene engineering research

Custom Solutions For IO Research

Looking for a more customized approach to your immuno-oncology research? Need something a little out of the ordinary? Let us help with our wide range of custom services development – from custom antibody and ELISA services to gene engineering, we have a service to suit all of your needs.

T cell-based therapies eBook cover

T Cell-Based Therapies eBook

This new eBook provides an overview of several biological and manufacturing challenges facing the development and production of T cell therapies. It follows with examples of how Bio-Techne products and services can address these challenges at each stage of the process.

Workflow solutions